Innovative analysis and future prospects of Bupleuri Radix’s pharmacology and toxicity based on the gut–liver axis

Abstract

Bupleuri Radix (BR) is a traditional Chinese medicine, which has a significant protective effect on liver and intestinal diseases, but its potential hepatotoxicity is still worrying. The bi-directional effects of BR are systematically summarized in this review, with a primary focus on the gut–liver axis. Saikosaponin, as the main bioactive components of BR, are converted by the gut microbiota into metabolites with enhanced bioavailability, thereby regulating the intestinal flora, strengthening the intestinal barrier, and alleviating inflammation through pathways such as NF-κB and PI3K/Akt/mTOR, and STAT3. Concurrently, BR and its components exert hepatoprotective effects through antioxidant, anti-inflammatory, and metabolic regulation mechanisms. However, saikosaponin and volatile oil may induce hepatotoxicity via oxidative stress and apoptosis. Critical evidence gaps persist regarding the systematic interplay between BR’s multi-component actions and the gut–liver axis, the toxicity of metabolites, and clinical hepatotoxicity risk. Future research should prioritize these areas to optimize the safe and effective application of BR.

Keywords

Bupleuri Radix / pharmacokinetics / gut–liver axis / intestinal disease / liver disease / toxicity

RIGHTS & PERMISSIONS

©Higher Education Press 2026

Just Accepted

This article has successfully passed peer review and final editorial review, and will soon enter typesetting, proofreading and other publishing processes. The currently displayed version is the accepted final manuscript. The officially published version will be updated with format, DOI and citation information upon launch. We recommend that you pay attention to subsequent journal notifications and preferentially cite the officially published version. Thank you for your support and cooperation.